Improved patient satisfaction using ingenol mebutate gel 0.015% for the treatment of facial actinic keratoses: a prospective pilot study
Joanna Emilio,1 Michelle Schwartz,2–4 Eleanor Feldman,2–4 Amy Kalowitz Bieber,2–4 Amanda Bienenfeld,2–4 Min-Kyung Jung,1 Daniel M Siegel,2,3 Orit Markowitz2–4 1Department of Dermatology, NYIT College of Osteopathic Medicine, Old Westbury, 2Department...
Saved in:
Main Authors: | Emilio J (Author), Schwartz M (Author), Feldman E (Author), Bieber AK (Author), Bienenfeld A (Author), Jung MK (Author), Siegel DM (Author), Markowitz O (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2016-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Treatment of actinic keratoses and cancerization field of the face and scalp with 0.015% ingenol mebutate gel in Brazilian individuals: safety, tolerability and patients' perspectives
by: Luiz Gameiro, et al.
Published: (2019) -
Nodular basal cell carcinoma of the face successfully treated with ingenol mebutate 0.015% gel
by: Silvia S. Iannazzone, et al.
Published: (2018) -
Assessment of local skin reactions with a sequential regimen of cryosurgery followed by ingenol mebutate gel, 0.015%, in patients with actinic keratosis
by: Goldenberg G, et al.
Published: (2014) -
Ingenol mebutate in the treatment of actinic keratoses: clearance rate and adverse effects
by: Maria Isabel Ramos Saraiva, et al.
Published: (2018) -
New developments in the treatment of actinic keratosis: focus on ingenol mebutate gel
by: Berman B
Published: (2012)